On Tuesday, December 30th, at 7 PM, I will be giving a talk just outside Tel Aviv, Israel at The Interdisciplinary Center (IDC) Herzliya. I was invited to speak as part of the Zell Entrepreneurship Program.
The Zell Entrepreneurship Program at IDC Herzliya is a venture creation program for outstanding undergraduate students in their final years of the schools of law, business, communications, computer science and government at the IDC Herzliya. The program, in its eighth year, is funded generously by Sam Zell of Chicago. It allows students to take an idea and work to develop it into a business in the course of an academic year.
The full title of my talk is "10 Common Assumptions Entrepreneurs Make That Kill Their Ventures: De-Risking Your Ideas and Increasing Your Chances of Success."
I will speak about the very common mistakes I see many entrepreneurs make regarding assumptions in their business models, not realizing they are making assumptions, how those assumptions are often deadly, and most importantly, how to de-risk those assumptions in a very quick and capital-efficient manner.
If you are building out a business plan for a new venture, expanding an existing company, creating a new product, or meeting with VC investors to pitch for funding, this will be a presentation you won’t want to miss.
As well, I will be speaking briefly about DreamIt Ventures.
DreamIt will once again be providing 12 teams with up to $30,000 in
funding and will have the companies relocate for June – August 2009 to
Philadelphia. During the 3 month program the teams will receive the
DreamIt funding as well as: an experienced 1 on 1 mentor; office space
with furniture and Internet connectivity; legal and accounting services
from some of the best firms in Philadelphia; a weekly speaker series
where expert speakers cover tricks and traps in
marketing, technology, product development, software architecture,
venture capital, etc.; and all of the software that Microsoft offers.
My talk will last for approximately 45 minutes with 15 minutes of Q&A.